|
RBM28 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.198800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.922200E-01 |
| Normal-vs-Stage2 |
6.437200E-01 |
| Normal-vs-Stage3 |
5.658400E-01 |
| Normal-vs-Stage4 |
6.343400E-01 |
| Stage1-vs-Stage2 |
6.947200E-01 |
| Stage1-vs-Stage3 |
5.882400E-01 |
| Stage1-vs-Stage4 |
4.688600E-01 |
| Stage2-vs-Stage3 |
9.539000E-01 |
| Stage2-vs-Stage4 |
3.987000E-01 |
| Stage3-vs-Stage4 |
3.272400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.937000E-01 |
| Normal-vs-AfricanAmerican |
4.514600E-01 |
| Normal-vs-Asian |
5.568200E-02 |
| Caucasian-vs-AfricanAmerican |
1.915620E-01 |
| Caucasian-vs-Asian |
6.528100E-02 |
| AfricanAmerican-vs-Asian |
2.391600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.739000E-01 |
| Normal-vs-Female |
3.526400E-01 |
| Male-vs-Female |
2.074000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.865000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.426000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.209800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.879700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.805600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.868200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.971400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.059400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.803700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.214990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.500570E-01 |
| Normal-vs-Grade 2 |
9.036800E-01 |
| Normal-vs-Grade 3 |
6.143800E-01 |
| Normal-vs-Grade 4 |
8.599600E-01 |
| Grade 1-vs-Grade 2 |
5.486200E-02 |
| Grade 1-vs-Grade 3 |
5.305500E-02 |
| Grade 1-vs-Grade 4 |
8.267700E-02 |
| Grade 2-vs-Grade 3 |
6.351400E-01 |
| Grade 2-vs-Grade 4 |
9.287600E-01 |
| Grade 3-vs-Grade 4 |
8.059800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.872600E-01 |
| Normal-vs-ccB subtype |
4.081400E-01 |
| ccA subtype-vs-ccB subtype |
1.468570E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.590600E-01 |
| Normal-vs-N1 |
8.484000E-01 |
| N0-vs-N1 |
9.274200E-01 |
|
|
